Frontier Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$532K Buy
9,046
+1,326
+17% +$79.3K 0.03% 151
2020
Q1
$430K Buy
+7,720
New +$472K 0.03% 153

Other funds holding BMY

Frontier Investment Management's BMY Position: Q2 2020 in Review

Frontier Investment Management increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2020, buying an estimated $79.3K and bringing the position to 9,046 shares worth $532K. The position accounts for 0.03% of the portfolio, ranked #151.

Frontier Investment Management first reported a position in BMY in Q1 2020 and has held it in 2 quarters since. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Frontier Investment Management held 9,046 shares of Bristol-Myers Squibb worth $532K as of Q2 2020.
  • Frontier Investment Management bought 1,326 Bristol-Myers Squibb shares in Q2 2020, an estimated $79.3K.
  • Bristol-Myers Squibb made up 0.03% of Frontier Investment Management's portfolio in Q2 2020, its #151 holding.
  • Frontier Investment Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 2 quarters since.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.